SPDR SER TR

Ticker: XBI CUSIP: 78464A870 Class: S&P BIOTECH

TRANSCEND CAPITAL ADVISORS, LLC's Holding History (CIK: 0001776082)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 29,539 Value ($000) $3,602 Avg Close Range
Q3 2025
Shares 34,068 Value ($000) $3,414 Avg Close Range
Q2 2025
Shares 34,067 Value ($000) $2,825 Avg Close Range
Q1 2025
Shares 48,553 Value ($000) $3,938 Avg Close Range
Q4 2024
Shares 49,350 Value ($000) $4,444 Avg Close Range
Q3 2024
Shares 50,834 Value ($000) $5,022 Avg Close Range
Q2 2024
Shares 54,109 Value ($000) $5,016 Avg Close Range
Q1 2024
Shares 50,335 Value ($000) $4,776 Avg Close Range
Q4 2023
Shares 48,204 Value ($000) $4,304 Avg Close Range
Q3 2023
Shares 31,599 Value ($000) $2,307 Avg Close Range
Q2 2023
Shares 12,779 Value ($000) $1,063 Avg Close Range
Q1 2023
Shares 12,805 Value ($000) $976 Avg Close Range
Q4 2022
Shares 13,702 Value ($000) $1,137 Avg Close Range
Q3 2022
Shares 18,647 Value ($000) $1,479 Avg Close Range
Q2 2022
Shares 18,525 Value ($000) $1,376 Avg Close Range
Q1 2022
Shares 15,083 Value ($000) $1,356 Avg Close Range
Q4 2021
Shares 15,207 Value ($000) $1,703 Avg Close Range
Q3 2021
Shares 4,945 Value ($000) $613 Avg Close Range
Q1 2021
Shares 6,265 Value ($000) $851 Avg Close Range
Q4 2020
Shares 6,232 Value ($000) $877 Avg Close Range
Q3 2020
Shares 7,670 Value ($000) $855 Avg Close Range